Made Scientific Partners With Orca Bio on Commercial Manufacturing of TREGZI

COMPANY PROFILE
  • Made Scientific has entered a long-term commercial manufacturing partnership with Orca Bio to provide manufacturing capacity for TREGZI, its FDA-approved cell therapy for adults with hematological malignancies, at Made Scientific’s Princeton, New Jersey, site.
  • Made Scientific plans to expand its Princeton operations with an additional 45,000-square-foot facility, supporting a bicoastal manufacturing network alongside Orca Bio’s Sacramento facility and increasing access to domestic and international donors.

Made Scientific, a U.S.-based cell therapy contract development and manufacturing organization (CDMO), has entered a long-term commercial manufacturing partnership with Orca Bio, a commercial-stage biotechnology company developing cell therapies for blood cancers and autoimmune diseases. Under the agreement, Made Scientific will provide manufacturing capacity at its Princeton, New Jersey, site for TREGZI™, Orca Bio’s FDA-approved cell therapy for allogeneic transplant in adults with hematological malignancies.

The Princeton site will serve as an East Coast manufacturing bridge, complementing Orca Bio’s main commercial manufacturing facility in Sacramento, California. The arrangement will establish a bicoastal production network that the companies say can help reduce delivery times for certain East Coast patients. It will also enable Orca Bio to manufacture products using European donors, expanding its donor sourcing flexibility.

Made Scientific plans to expand its Princeton operations with an additional 45,000-square-foot facility next to its existing site, creating a Princeton manufacturing campus. The planned facility will include additional commercial-scale manufacturing suites, quality control laboratories, warehousing and cryogenic storage. Made Scientific is progressing toward FDA licensure of its Princeton facilities to support Orca Bio’s commercial supply.

“Commercial supply is a decades-long commitment to patients, and it starts with capacity that is ready when a therapy is. Orca Bio is building its East Coast manufacturing network with us, and our expansion on the Princeton campus gives us room to grow with them as TREGZI reaches more patients.”

Syed T. Husain, chairman and CEO of Made Scientific

“The Princeton site would complement the company’s Sacramento operations and provide further access to domestic and international donors. Made Scientific’s support across clinical and commercial manufacturing would help Orca Bio expand patient access.”

Orca Bio Co-founder and President Jeroen Bekaert
EXCLUSIVE DOWNLOAD

Download the full CDMO Live Report for 112 pages of insights and best practices in external manufacturing.